$321 Million is the total value of Krensavage Asset Management, LLC's 16 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 66.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | BIOVERATIV INC | $39,376,000 | +9.6% | 730,260 | +16.0% | 12.27% | +9.6% | |
MCK | New | MCKESSON CORP | $19,725,000 | – | 126,482 | +100.0% | 6.15% | – |
AMGN | New | AMGEN INC | $15,212,000 | – | 87,477 | +100.0% | 4.74% | – |
JNP | Buy | JUNIPER PHARMACEUTICALS INC | $2,134,000 | +92.9% | 440,102 | +81.0% | 0.66% | +92.8% |
DRAD | Buy | DIGIRAD CORP | $912,000 | -20.9% | 354,179 | +6.0% | 0.28% | -20.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
INVACARE CORP | 28 | Q3 2021 | 5.8% |
RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
MCKESSON CORP | 20 | Q3 2022 | 16.3% |
BIOGEN INC | 19 | Q3 2023 | 16.0% |
MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SCHEDULE 13G | 2024-02-27 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-15 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-16 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-15 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-17 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.